首页> 外文期刊>Pharmacology, Biochemistry and Behavior >Pharmacological identification of SM-21, the novel sigma(2) antagonist.
【24h】

Pharmacological identification of SM-21, the novel sigma(2) antagonist.

机译:新型sigma(2)拮抗剂SM-21的药理学鉴定。

获取原文
获取原文并翻译 | 示例
           

摘要

SM-21 is a tropane analogue with high affinity and selectivity for sigma(2) receptor subtype. In the absence of highly selective sigma(2) antagonists, the aim of the present study was to determine whether SM-21 is endowed with antagonistic activity. The experiments were conducted in rats by inducing neck dystonia, which is reported to be subsequent to activation of sigma(2) receptors. SM-21 (10 nmol/0.5 microl) was able to prevent torsion of the neck obtained by administration of the sigma(1)-sigma(2) agonist 1,3-di-(2-tolyl)guanidine (DTG, 5 nmol/0.5 microl) in the red nucleus. These data indicate that SM-21 is a potent and selective sigma(2) antagonist.
机译:SM-21是对sigma(2)受体亚型具有高亲和力和选择性的托烷类似物。在没有高度选择性的sigma(2)拮抗剂的情况下,本研究的目的是确定SM-21是否具有拮抗活性。该实验是通过诱导颈部肌张力障碍在大鼠中进行的,据报道这是在激活sigma(2)受体之后进行的。 SM-21(10 nmol / 0.5 microl)能够预防通过施用sigma(1)-sigma(2)激动剂1,3-二-(2-甲苯基)胍(DTG,5 nmol)获得的颈部扭转/0.5微升)在红色核中。这些数据表明SM-21是有效的选择性sigma(2)拮抗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号